Minerco (MINE) Responds To SEC Suspension of Trading on OTC Markets
Company Will Fully Cooperate With SEC In A Timely Manner ANN ARBOR, MI / ACCESSWIRE…
Month: June 2021
Amex Appoints Dr. Luisa Morena to Board of Directors and Strengthens Corporate Governance
MONTREAL, QC / ACCESSWIRE / June 4, 2021 / Amex Exploration Inc. (“Amex or the Company”)…
Crexendo to Present at LD Micro Invitational as Hall of Fame Presenter
PHOENIX, AZ / ACCESSWIRE / June 4, 2021 / Crexendo, Inc. (NASDAQ:CXDO) an award-winning premier…
Gold Springs Resource Drills 7 More Holes at Gold Springs; Brings Total to 22 Holes in 2021 Program, Assay Results Pending
VANCOUVER, BC / ACCESSWIRE / June 4, 2021 / Gold Springs Resource Corp. (TSX:GRC) (OTCQB:GRCAF)…
Daniel Dusina Joins Blue Chip Partners as Director of Investments
FARMINGTON HILLS, MI / ACCESSWIRE / June 4, 2021 / Blue Chip Partners is excited…
This Week on MoneyTV with Donald Baillargeon, 6/4
HOLLYWOOD, CA / ACCESSWIRE / June 4, 2021 / Press release importance, solar and roofing integration,…
R2 Recycling Is Taking The Right Steps For Proper IT Asset Management
LAKEWOOD, NJ / ACCESSWIRE / June 4, 2021 / Over the span of less than…
T Stamp Inc Announces Successful Completion of a Private Offering
US $4 million raised from new and existing Shareholders in private fundraise ATLANTA, GA /…
Avnio Launches New Solution Enabling Businesses to Supercharge Salesforce Data
London-based software company Avnio, unveils Tables to help organisations increase productivity, drive insights and create…
Pharvaris Presents Pharmacokinetic and Pharmacodynamic Data for Oral PHA121, Under Development for the Treatment of HAE, at 12th C1 Inhibitor Deficiency and Angioedema Workshop
ZUG, Switzerland, June 04, 2021 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company focused…
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Mechelen, Belgium; 4 June 2021; 07.01 CET; – Galapagos NV (Euronext & Nasdaq: GLPG) today…
Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for…
Coherus and Junshi Biosciences Announce Toripalimab in Combination with Chemotherapy Met Primary Progression Free Survival (PFS) Endpoint as First Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
– In pivotal Phase 3 JUPITER-02 study, toripalimab plus chemotherapy significantly improved PFS compared to…
Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera
At final analysis, study showed clinically relevant improvement in median overall survival with a difference…
Coherus and Junshi Biosciences Announce Toripalimab in Combination with Chemotherapy Met Primary Progression Free Survival (PFS) Endpoint as First Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
– In pivotal Phase 3 JUPITER-02 study, toripalimab plus chemotherapy significantly improved PFS compared to…
ECMOHO Limited Announces First Quarter 2021 Unaudited Financial Results
SHANGHAI, China, June 04, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the…
New Phase 3 Data at WCPGHAN Show Long-Term Safety, Tolerability, and Treatment Benefits of Bylvay™ (odevixibat) in PFIC
– Data being presented show long-term benefits of Bylvay in children with PFIC – –…
Vincerx Pharma Announces First Patient Dosed in Phase 1b Study of VIP152 in MYC-Driven Relapsed or Refractory Aggressive Lymphomas and Advanced Solid Tumors
First patient dosed by Vincerx marks significant milestone in Company’s development PALO ALTO, Calif., June…
Zealand Pharma to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
Company announcement – No. 36/ 2021 Zealand Pharma to Participate in Goldman Sachs 42nd Annual…
Bioasis Announces Publication Validating its xB³ ™ Platform Technology for CNS Therapeutics
NEW HAVEN, Conn., June 03, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…